Kelyniam Corporate Update

A RECORD YEAR FOR KLYG!

CANTON, Conn., Jan. 21, 2025 /PRNewswire/ -- Ross Bjella, Kelyniam's CEO, announced today a number of important updates ahead of the recurring announcements associated with the Company's traditional March corporate disclosures: 

https://us02web.zoom.us/meeting/register/vZE43p_zSw-_ZjY47nvETQ

"Kelyniam left 2024 with strong momentum and we are excited about the prospects for the business in 2025," said Bjella.

Other information regarding the Company can be found on the company's website at www.Kelyniam.com.

Kelyniam Inc., specializes in the rapid production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers.  The Company develops, manufactures, and distributes custom cranial and maxillo-facial implants for patients.  Kelyniam works directly with surgeons, health systems and payors to improve clinical and cost-of-care outcomes. Kelyniam's web site address is www.Kelyniam.com.

As a cautionary note to investors, certain matters discussed in this press release are forward-looking statements. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the Company's ability to execute its service and product sales plans; and changes in the status of ability to market products. 

SOURCE Kelyniam Global Inc